Stem Cell Therapeutic and Research Reauthorization Act of 2015
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in senate (Nov 16, 2015)
Stem Cell Therapeutic and Research Reauthorization Act of 2015
This bill amends the Public Health Service Act and the Stem Cell Therapeutic and Research Act of 2005 to revise and extend through FY2020 the C.W. Bill Young Cell Transplantation Program and the National Cord Blood Inventory program. (These programs help match patients in need of a transplant with unrelated bone marrow and cord blood donors.)
The Department of Health and Human Services (HHS) must review the state of the science of using adult stem cells and birthing tissues to develop new therapies and consider the inclusion of new therapies in the C.W. Bill Young Cell Transplantation Program.
Requirements for HHS contracts under the Stem Cell Therapeutic and Research Act of 2005 are revised.
HHS must determine whether to include peripheral blood stem cells and umbilical cord blood in the definition of human organ.What just happenedNov 16, 2015
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S7968-7969)
Who’s behind it
- Introduced in SenateNov 16, 2015
- Nov 16, 2015IntroReferral
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S7968-7969)
Health, Education, Labor, and Pensions Committee - Nov 16, 2015IntroReferral10000
Introduced in Senate